Amrutanjan Health Care is currently trading at Rs. 783.30, up by 11.40 points or 1.48% from its previous closing of Rs. 771.90 on the BSE.
The scrip opened at Rs. 779.85 and has touched a high and low of Rs. 804.85 and Rs. 777.05 respectively. So far 26,000 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 996.80 on 25-Jul-2011 and a 52 week low of Rs. 610.00 on 15-Mar-2011.
Last one week high and low of the scrip stood at Rs. 804.85 and Rs. 738.50 respectively. The current market cap of the company is Rs. 250.00 crore.
The promoters holding in the company stood at 50.71% while Institutions and Non-Institutions held 0.16% and 49.13% respectively.
The company has posted a rise of 35.11% in its net profit at Rs 4.31 crore for the quarter ended December 31, 2011 as compared to Rs 3.19 crore for the same quarter in the previous year. Total income has increased by 6.25% at Rs 36.36 crore for the quarter under review as compared to Rs 34.22 crore in the same quarter of 2010.
Amrutanjan Health Care has a wide range of ayurvedic and allopathic products. The company has diversified into various businesses in the health care segment like the Fine Chemical Division and Osmosys Medical Clinic located in Chennai. The company is also planning to consolidate its flagship product category - pain management - to compete with multinational brands such as GSK (Iodex), P&G (Vicks) and Reckitt Benckiser (Moov), more vigorously.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1948.90 |
Dr. Reddys Lab | 6746.05 |
Cipla | 1671.60 |
Lupin | 2213.50 |
Zydus Lifesciences | 1074.60 |
View more.. |